Stocks and Investing
Stocks and Investing
Thu, December 21, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, December 20, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael Turrin Upgraded (BLND) to Buy and Increased Target to $3.5 on, Dec 20th, 2023
Michael Turrin of Wells Fargo, Upgraded "Blend Labs, Inc." (BLND) to Buy and Increased Target from $1.5 to $3.5 on, Dec 20th, 2023.
Michael has made no other calls on BLND in the last 4 months.
There are 2 other peers that have a rating on BLND. Out of the 2 peers that are also analyzing BLND, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Joseph Vafi of "Canaccord Genuity" Reiterated at Hold and Held Target at $2 on, Wednesday, September 27th, 2023
This is the rating of the analyst that currently disagrees with Michael
- Michael Ng of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $1.6 on, Wednesday, November 8th, 2023
Contributing Sources